Volume 23 Issue 11
Nov.  2025
Turn off MathJax
Article Contents
HONG Yanqing, HU Chenliang. Factors influencing the occurrence of diabetic nephropathy and correlation analysis with non-HDL-C and TyG indices[J]. Chinese Journal of General Practice, 2025, 23(11): 1889-1891. doi: 10.16766/j.cnki.issn.1674-4152.004253
Citation: HONG Yanqing, HU Chenliang. Factors influencing the occurrence of diabetic nephropathy and correlation analysis with non-HDL-C and TyG indices[J]. Chinese Journal of General Practice, 2025, 23(11): 1889-1891. doi: 10.16766/j.cnki.issn.1674-4152.004253

Factors influencing the occurrence of diabetic nephropathy and correlation analysis with non-HDL-C and TyG indices

doi: 10.16766/j.cnki.issn.1674-4152.004253
Funds:

 AHWJ2023BAc20027

  • Received Date: 2024-10-14
    Available Online: 2026-01-07
  •   Objective  To analyze the relationship between non-high-density lipoprotein cholesterol (non-HDL-C), triglyceride glucose (TyG) index and diabetic nephropathy (DN), and to explore the risk factors for DN.  Methods  A retrospective analysis was conducted on 300 patients with type 2 diabetes mellitus (T2DM) who were admitted to Huangshan People's Hospital from July 2022 to July 2024. The patients were divided into the occurrence group (n=120) and non-occurrence group (n=180) according to the presence or absence of DN. The non-HDL-C and TyG index in the two groups were compared using a paired t-test, and the factors affecting DN were analyzed using a logistic regression analysis. The relationship between non-HDL-C, TyG index and DN was analyzed using Pearson's correlation coefficient.  Results  The mean levels of non-HDL-C [(4.98±1.10) mmol/L vs. (4.22±1.26) mmol/L, t=5.480, P < 0.05] and TyG index [(9.16±2.04) mmol/L vs. (7.90±1.75) mmol/L, t=5.714, P < 0.05] were higher in the occurrence group were higher than those in the non-occurrence group. The findings of this study indicate that non-HDL-C (OR=1.745, 95% CI: 1.318-2.311) and TyG index (OR=1.453, 95% CI: 1.219-1.732) are risk factors for DN in T2DM patients (P < 0.05). The present study found a positive correlation between non-HDL-C (r=0.405) and TyG index (r=0.498) and DN (P < 0.05).  Conclusion  The non-HDL-C and TyG index have been identified as risk factors for the development of DN in T2DM patients, and are closely associated with the occurrence of DN. In order to reduce the occurrence of DN, clinical combination and early targeted intervention are required.

     

  • loading
  • [1]
    DEMIRELLI B, BOZTEPE B, şENOL E G, et al. Non-diabetic nephropathy in diabetic patients: incidence, HbA1c variability and other predictive factors, and implications[J]. Int Urol Nephrol, 2024, 56(9): 3091-3100. doi: 10.1007/s11255-024-04066-w
    [2]
    PEÑA A S, CURRAN J A, FUERY M, et al. Screening, assessment and management of type 2 diabetes mellitus in children and adolescents: australasian paediatric endocrine group guidelines[J]. Med J Aust, 2020, 213(1): 30-43. doi: 10.5694/mja2.50666
    [3]
    LIU X M, GUO Y P, WU J, et al. Discrimination of chronic kidney disease and diabetic nephropathy and analysis of their related influencing factors[J]. Diabetes Metab Syndr Obes, 2020, 13: 5085-5096. doi: 10.2147/DMSO.S275398
    [4]
    冯玲, 梁维, 赵静, 等. 糖尿病肾病患者临床特点及预后影响因素分析[J]. 海南医学, 2021, 32(22): 2915-2917.

    FENG L, LIANG W, ZHAO J, et al. Analysis of clinical characteristics and prognostic factors affecting patients with diabetic nephropathy[J]. Hainan Medicine, 2021, 32(22): 2915-2917.
    [5]
    荣萍萍, 黄宇玲, 张欣悦, 等. 中性粒细胞计数与高密度脂蛋白胆固醇比值与早发冠心病的相关性分析[J]. 医学研究杂志, 2023, 52(8): 100-104, 117.

    RONG P P, HUANG Y L, ZHANG X Y, et al. Correlation analysis of neutrophil count and high-density lipoprotein cholesterol ratio with early-onset coronary heart disease[J]. Journal of Medical Research, 2023, 52(8): 100-104, 117.
    [6]
    RAMDAS NAYAK V K, SATHEESH P, SHENOY M T, et al. Triglyceride glucose (TyG) index: a surrogate biomarker of insulin resistance[J]. J Pak Med Assoc, 2022, 72(5): 986-988. doi: 10.47391/JPMA.22-63
    [7]
    中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志, 2021, 13(4): 315-409.

    Chinese Society of Diabetics. Chinese Guidelines for the Prevention and treatment of type 2 diabetes(2020 edition)[J]. Chinese Journal of Endocrinology and Metabolism, 2021, 13(4): 315-409.
    [8]
    中华医学会肾脏病学分会专家组. 糖尿病肾脏疾病临床诊疗中国指南[J]. 中华肾脏病杂志, 2021, 37(3): 255-304.

    Chinese Society of Nephrology expert group. Chinese guide for clinical diagnosis and treatment of diabetic kidney disease[J]. Chinese Journal of Nephrology, 2021, 37(3): 255-304.
    [9]
    KONDAPI K, SILAMBANAN S, MOORTHY S, et al. A study of the risk factors and urinary podocin as an early prognostic indicator of renal injury in diabetic nephropathy[J]. J Assoc Physicians India, 2021, 69(6): 11-12.
    [10]
    王雅灏, 王颜刚, 周月, 等. 水飞蓟素对糖尿病肾病蛋白尿水平影响Meta分析[J]. 青岛大学学报(医学版), 2020, 56(6): 667-670.

    WANG Y H, WANG Y G, ZHOU Y, et al. Meta-analysis of the effect of silymarin on the level of proteinuria in diabetic nephropathy[J]. Journal of Qingdao University(Med Edition), 2020, 56(6): 667-670.
    [11]
    SIDDIQUI K, GEORGE T P, JOY S S, et al. Risk factors of chronic kidney disease among type 2 diabetic patients with longer duration of diabetes[J]. Front Endocrinol(Lausanne), 2022, 12(13): 1079725. DOI: 10.3389/fendo.2022.1079725.
    [12]
    杨建享, 林永强. 高通量血液透析对老年糖尿病肾病患者心功能超声指标、血清心肌损伤及炎症生化指标的远期改善作用[J]. 中华全科医学, 2024, 22(11): 1884-1886, 1989. doi: 10.16766/j.cnki.issn.1674-4152.003756

    YANG J X, LIN Y Q. Long-term improvement of ultrasound indexes, serum myocardial injury and inflammatory biochemical indexes in elderly patients with diabetic nephropathy by high-throughput hemodialysis[J]. Chinese Journal of General Medicine, 2024, 22(11): 1884-1886, 1989. doi: 10.16766/j.cnki.issn.1674-4152.003756
    [13]
    任梦玉, 周婉, 范文华, 等. 2型糖尿病患者合并肾脏病的相关危险因素分析[J]. 中国临床保健杂志, 2023, 26(2): 233-236.

    REN M Y, ZHOU W, FAN W H, et al. Risk factors related to kidney disease in patients with type 2 diabetes mellitus[J]. Chinese Journal of Clinical Health, 2023, 26(2): 233-236.
    [14]
    TAO L C, XU J N, WANG T T, et al. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations[J]. Cardiovasc Diabetol, 2022, 21(1): 68. DOI: 10.1186/s12933-022-01511-x.
    [15]
    MA Y, REN Y Q, HUI D, et al. Nomogram analysis of the influencing factors of rapid renal decline in patients with biopsy-proven diabetic nephropathy in type 2 diabetes[J]. Clin Nephrol, 2023, 99(6): 274-282. doi: 10.5414/CN111065
    [16]
    李涛, 张曼. 基于Cox回归分析筛选2型糖尿病肾病发生的危险因素[J]. 标记免疫分析与临床, 2023, 30(10): 1649-1653.

    LI T, ZHANG M. Screening risk factors for type 2 diabetic nephropathy based on Cox regression analysis[J]. Journal of Marker Immunoassay and Clinical Analysis, 2023, 30(10): 1649-1653.
    [17]
    王丹丹, 李瑾. 血NLR及Cysc评估早期糖尿病肾病的预测价值研究[J]. 医药论坛杂志, 2023, 44(2): 5-8.

    WANG D D, LI J. Study on predictive value of blood NLR and Cysc in evaluating early diabetic nephropathy[J]. Journal of Medical Forum, 2023, 44(2): 5-8.
    [18]
    SOHOULI M H, MIRMIRAN P, SERAJ S S, et al. Impact of low-protein diet on cardiovascular risk factors and kidney function in diabetic nephropathy: a systematic review and meta-analysis of randomized-controlled trials[J]. Diabetes Res Clin Pract, 2022, 191: 110068. DOI: 10.1016/j.diabres.2022.110068.
    [19]
    Al-ZAHRANI N, ALSWAT H K, ALQARNI A M, et al. Prevalence and risk factors of diabetic nephropathy among saudi type-1 diabetic patients in Taif City, Saudi Arabia[J]. Diabetes Metab Syndr Obes, 2023, 11(16): 3609-3616.
    [20]
    NATESAN V, KIM S J. Diabetic nephropathy-a review of risk factors, progression, mechanism, and dietary management[J]. Biomol Ther(Seoul), 2021, 29(4): 365-372. doi: 10.4062/biomolther.2020.204
    [21]
    JANSEN R B, HOLSTEIN P E, JORGENSEN B, et al. Risk factors for development of nephropathy in patients with a diabetic charcot foot[J]. BMC Res Notes, 2021, 14(1): 403. DOI: 10.1186/s13104-021-05811-5.
    [22]
    田蓉, 傅桂芬, 李丽蓉, 等. 老年T2DM合并高血压患者发生糖尿病肾病的影响因素[J]. 心血管康复医学杂志, 2023, 32(1): 4-8.

    TIAN R, FU G F, LI L R, et al. Influence factors of diabetic nephropathy in elderly patients with T2DM combined with hypertension[J]. Journal of Cardiovascular Rehabilitation Medicine, 2023, 32(1): 4-8.
    [23]
    张健, 胡怡. 2型糖尿病患者并发糖尿病肾病的危险因素及Nomogram风险预测模型构建[J]. 广西医科大学学报, 2023, 40(11): 1843-1849.

    ZHANG J, HU Y. Construction of a Nomogram risk prediction model and risk factors of diabetic nephropathy in type 2 diabetic patients[J]. Journal of Guangxi Medical University, 2023, 40(11): 1843-1849.
    [24]
    孙水雅, 桂薇薇, 贾程芳, 等. 浙江省基层2型糖尿病患者糖尿病肾病危险因素的列线图分析[J]. 中华内科杂志, 2023, 62(2): 169-175.

    SUN S Y, GUI W W, JIA C F, et al. Analysis of risk factors of diabetic nephropathy in patients with type 2 diabetes mellitus in Zhejiang Province[J]. Chinese Journal of Internal Medicine, 2023, 62(2): 169-175.
    [25]
    雷程灏, 尹倩, 朱叶. 糖化血红蛋白变异指数与2型糖尿病肾病的相关性研究[J]. 临床内科杂志, 2022, 39(6): 396-399.

    LEI C H, YIN Q, ZHU Y. Association between hemoglobin glycation index and diabetic nephropathy of type 2 diabetic mellitus[J]. Journal of Clinical Internal Medicine, 2022, 39(6): 396-399.
    [26]
    YU D H, WANG Z, ZHANG X X, et al. Remnant cholesterol and cardiovascular mortality in patients with type 2 diabetes and Incident diabetic nephropathy[J]. J Clin Endocrinol Metab, 2021, 106(12): 3546-3554.
    [27]
    XUAN X P, HAMAGUCHI M, CAO Q L, et al. U-shaped association between the triglyceride-glucose index and the risk of incident diabetes in people with normal glycemic level: a population-base longitudinal cohort study[J]. Clin Nutr, 2021, 40(4): 1555-1561. doi: 10.1016/j.clnu.2021.02.037
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Article Metrics

    Article views (35) PDF downloads(1) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return